Deerfield Management Company, L.P. (Series C) Hille Vax, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Hille Vax, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,882,654 shares of HLVX stock, worth $3.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,882,654
Previous 4,004,231
52.98%
Holding current value
$3.5 Million
Previous $57.9 Million
94.28%
% of portfolio
0.06%
Previous 1.22%
Shares
7 transactions
Others Institutions Holding HLVX
# of Institutions
80Shares Held
36.8MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$19.7 Million1.01% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$9.15 Million0.74% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.89 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.64 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC1.84MShares$3.42 Million0.49% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $62.2M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.